Effects of angiotensin II type 1 receptor antagonist, YM358, on cardiac hypertrophy and dysfunction after myocardial infarction in rats.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1248/BPB.25.857PMID 12132657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.

  2001cited by this paper
• Attenuation of Cardiac Failure, Dilatation, Damage, and Detrimental Interstitial Remodeling Without Regression of Hypertrophy in Hypertensive Rats

  2001cited by this paper
• Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.

  2000cited by this paper
• Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.

  1999cited by this paper
• Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction.

  1999cited by this paper
• Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.

  1998cited by this paper
• Reduced responsiveness of rat mesenteric resistance artery smooth muscle to phenylephrine and calcium following myocardial infarction

  1997cited by this paper
• Antihypertensive effect of repeatedly administered YM358, an angiotensin AT1-receptor antagonist, in stroke-prone spontaneously hypertensive rats.

  1997cited by this paper
• Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction.

  1997cited by this paper
• Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs.

  1997cited by this paper
• Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.

  1997cited by this paper
• Angiotensin and bradykinin peptides in rats with myocardial infarction.

  1997cited by this paper
• Oral angiotensin-converting-enzyme inhibitors.

  1997cited by this paper
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

  1997cited by this paper
• Angiotensin II in the evolution of experimental heart failure.

  1996cited by this paper
• Cardiomegaly and vasoactive hormones in rats with chronic myocardial infarction: long-term effects of chlorothiazide.

  1996cited by this paper
• Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II.

  1995cited by this paper
• Left ventricular remodeling after acute myocardial infarction.

  1995cited by this paper
• Does ACE inhibition limit structural changes in the heart following myocardial infarction?

  1995cited by this paper
• Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

  1994cited by this paper
• Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats.

  1993cited by this paper
• Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat.

  1993cited by this paper
• Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes

  1993cited by this paper
• Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure.

  1991cited by this paper
• An overview of contemporary etiologies of congestive heart failure.

  1991cited by this paper
• Angiotensin and the remodelling of the myocardium.

  1989cited by this paper
• Myocardial Infarct Size and Ventricular Function in Rats

  1979cited by this paper
• CIRCULATION

  1964cited by this paper

• Insulin signaling: a possible pathogenesis of cardiac hypertrophy.

  2010cites this paper
• An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.

  2007cites this paper
• Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways.

  2006cites this paper
• Prevention of Cardiac Hypertrophy by Angiotensin II Type-2 Receptor Gene Transfer

  2004cites this paper
• Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension.

  2004cites this paper
• DEFINING THE ROLE OF THE ANGIOTENSIN II TYPE 2 RECEPTOR IN CARDIOVASCULAR DISEASE

  2004cites this paper